BRIDGEBIO PHARMA INC

CUSIP: 10806XAD4 Class: Convertible Debt

Voya Investment Management LLC's Holding History (CIK: 0001068837)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 30,000,000 Value ($000) $33,788 Avg Close — Range —
Q3 2025
Shares 30,000,000 Value ($000) $29,648 Avg Close — Range —
Q2 2025
Shares 118,175,000 Value ($000) $110,612 Avg Close — Range —
Q1 2025
Shares 118,175,000 Value ($000) $106,535 Avg Close — Range —
Q4 2024
Shares 74,675,000 Value ($000) $64,071 Avg Close — Range —
Q3 2024
Shares 74,675,000 Value ($000) $62,727 Avg Close — Range —
Q2 2024
Shares 80,295,000 Value ($000) $63,983 Avg Close — Range —
Q1 2024
Shares 80,295,000 Value ($000) $65,790 Avg Close — Range —
Q4 2023
Shares 94,275,000 Value ($000) $80,313 Avg Close — Range —
Q3 2023
Shares 94,275,000 Value ($000) $70,706 Avg Close — Range —
Q2 2023
Shares 108,065,000 Value ($000) $66,879 Avg Close — Range —
Q1 2023
Shares 108,065,000 Value ($000) $69,956 Avg Close — Range —
Q4 2022
Shares 87,065,000 Value ($000) $33,248 Avg Close — Range —
Q3 2022
Shares 89,065,000 Value ($000) $39,518 Avg Close — Range —